AzTrials
AzTrials

Depression/AnxietyNCT06887569

Using Financial Incentives and Screening to Increase Engagement With Mental Health Services Among College Students in Chennai, India

A study testing Rewards and Screening in people with Depression/Anxiety, run by Massachusetts Institute of Technology at 1 site in India.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will evaluate the effectiveness of interventions to increase engagement with mental health services among a sample of college students in Chennai, India. The study is being conducted in partnership with an arts and science college for women in Chennai. Read more about this study

Who is it for?
Ages 18 to 30 years, women onlyHealthy volunteers can take part
Conditions the study is for
Depression/Anxiety
What is being tested?
Rewards and Screening
Could I receive a placebo?
No, everyone receives an active treatment
How many people
340 participants
Where
1 siteIndia
Study dates
20 Jan 2025to 25 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • aged 18-30
  • are present in the classrooms,
  • consent to participate in the study

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

India1 site
  • College campus

    Chennai, Tamil Nadu

Other trials in India

About this study

This study will evaluate the effectiveness of interventions to increase engagement with mental health services among a sample of college students in Chennai, India. The study is being conducted in partnership with an arts and science college for women in Chennai. The sample will be recruited within classrooms, during college hours. All students present in the classroom per the allotted time will be introduced to the study. The research team will obtain consent from those interested after screening them for age eligibility (between the ages of 18 and 30 years). Study participants will then complete a baseline survey including questions around demographics, perceptions of their own mental health, mental health treatment history, and the PHQ-ADS, a standardized composite screening tool for depression and anxiety. The experimental design is an RCT with 4 groups, randomized at the individual level: (1) a control group, which will watch a video with information about mental health and be able to access therapy in college and at SCARF, a mental health center in Chennai, at no cost for the duration of the study; (2) a screening group, in which, in addition to the interventions in the control group, students will be informed whether their responses to the PHQ-ADS questions fit in the standard risk categories of no, mild, moderate, or severe distress and corresponding recommendations for whether to make an appointment with a counselor/therapist; (3) a rewards group, in which, in addition to the interventions in the control group, students will be provided with a cash payment for attending their first therapy session; and (4) a combined screening and rewards group. The investigators will measure interest in, and take-up of, therapy at the individual level.

Being tested
Rewards, Screening
Medical subject headings
Depression, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RewardsBehavioural

    Financial rewards for attending therapy

  • ScreeningBehavioural

    Information about screening for depression and anxiety

Study groups in NCT06887569
Study groupRoleWhat they receive
ControlNo interventionInformation about mental health and therapy and free access to therapy
ScreeningExperimentalInformation about screening for depression and anxiety. Information about mental health and therapy and free access to therapy
Receives: Behavioral: Screening
RewardsExperimentalFinancial rewards for attending therapy. Information about mental health and therapy and free access to therapy
Receives: Behavioral: Rewards
Screening + RewardsExperimentalInformation about screening for depression and anxiety, and financial rewards for attending therapy (combination of previous two treatments). Information about mental health and therapy and free access to therapy
Receives: Behavioral: Rewards; Behavioral: Screening

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of participants expressing interest in therapy

    Student stating interest in the participant survey in booking an appointment with a study counselor, or asking to be contacted by a study counselor to discuss mental health and therapy

    Measured: Immediately after treatment (Day 1)

  2. Proportion of participants making an appointment

    student completing the process to make an appointment for therapy with a study counselor, through the participant survey or otherwise

    Measured: From enrolment until two months after enrolment

Secondary outcomes (3)
  1. Proportion of participants taking-up of a mental health care app

    This is measured in two ways: participants expressing interest in accessing a mental-healthcare app in the survey, and participants actually clicking a link to download the app.

    Measured: Immediately after treatment (Day 1)

  2. Proportion of participants demanding for information about mental health

    This is measured in two ways: participants expressing interest in receiving more information about mental health, and participants actually clicking a link to access the information

    Measured: Immediately after treatment (Day 1)

  3. Proportion of participants attending therapy sessions

    Data will be collected from the administrative records of the counselling office on whether participants actually attended a therapy session, as well as the number of sessions attended.

    Measured: From enrolment until two months after enrolment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2025
  2. Study start20 Jan 2025
  3. Primary completion25 May 2025
  4. Study completion25 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
340 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06887569
Sponsor's protocol ID
2206000666
Status last verified
Sep 2025
First submitted
6 Mar 2025
Last updated
25 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual-level data will be posted online

Questions about this trial

What is this clinical trial studying?

A study testing Rewards and Screening in people with Depression/Anxiety, run by Massachusetts Institute of Technology at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of participants expressing interest in therapy (time frame: Immediately after treatment (Day 1)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in